Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1562665 | 0.84 | TSHR (0.42) | TSHRMAPTKDM4ERAB9AGAA | |
| SCHEMBL3156953 | 0.75 | KDM4E (0.46) | KCNN4TSHRMAPTKDM4EMAPK1 | |
| SCHEMBL1564248 | 0.75 | KCNN4 (0.40) | KCNN4TSHRMAPTKDM4ETDP1 | |
| SCHEMBL687803 | 0.70 | NOTUM (0.44) | KCNN4TSHRMAPTKDM4EGAA | |
| SCHEMBL8000263 | 0.70 | TP53 (0.38) | TSHRMAPTKDM4EMAPK1TDP1 | |
| SCHEMBL3152689 | 0.70 | MEN1 (0.45) | KCNN4TSHRMAPTKDM4EMAPK1 | |
| SCHEMBL5269393 | 0.69 | TSHR (0.47) | KCNN4TSHRMAPTKDM4EMAPK1 | |
| SCHEMBL7473643 | 0.69 | KDM4E (0.41) | KCNN4TSHRMAPTKDM4EMAPK1 | |
| SCHEMBL1564264 | 0.69 | ALDH1A1 (0.42) | KCNN4TSHRMAPTKDM4EGAA | |
| SCHEMBL1829222 | 0.69 | SIRT2 (0.47) | KCNN4TSHRMAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743447-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743178-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025016906-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2025-01-23 | — | — | WO | disclosed |
| WO-2025016909-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2025-01-23 | — | — | WO | disclosed |
| CN-113683574-B | Method for synthesizing 1-methyl-1H-1, 2, 4-triazole-3-methyl formate | 上海晋鲁医药科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-113683574-A | Method for synthesizing 1-methyl-1H-1, 2, 4-triazole-3-methyl formate | 上海晋鲁医药科技有限公司 | 2021-11-23 | — | — | CN | disclosed |